These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2450926)

  • 1. The elimination of mycoplasma from infected hybridomas by passaging in BALB/c mice.
    Carroll K; O'Kennedy R
    J Immunol Methods; 1988 Apr; 108(1-2):189-93. PubMed ID: 2450926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of mycoplasma, bacteria, and fungi contaminants of hybridoma cultures by intraperitoneal passage in the mouse.
    Roseto A; Guillemin MC; Chehimi J; Mazeron MC; Périès J
    Hybridoma; 1984; 3(3):297-300. PubMed ID: 6500586
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of a mycoplasma elimination reagent on a mycoplasma-contaminated hybridoma cell line.
    Kumar A; Ali A; Yerneni LK
    Hybridoma (Larchmt); 2007 Apr; 26(2):104-6. PubMed ID: 17451359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three methods for curing hybridomas from mycoplasma contamination.
    Ravaoarinoro M; Lecomte J
    Hybridoma; 1988 Feb; 7(1):79-86. PubMed ID: 2453449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of monoclonal antibodies for the detection of cell infecting mycoplasmas.
    Douma R; Dular R; Brodeur BR; Kasatiya SS
    J Immunol Methods; 1989 Nov; 124(2):197-203. PubMed ID: 2513356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation.
    Jakway JP; Shevach EM
    J Immunol Methods; 1984 Mar; 67(2):337-45. PubMed ID: 6608555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycoplasma infection as a possible cause of hybridoma instability].
    Volgareva GM; Neustroeva VV; Sviridov VV
    Mol Gen Mikrobiol Virusol; 1985 Jan; (1):34-8. PubMed ID: 3879880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of mycoplasma contamination in hybridoma technology.
    Bongertz V; Thomaz N
    Mem Inst Oswaldo Cruz; 1988; 83(2):265-6. PubMed ID: 2593826
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of mycoplasmas from mouse myeloma cells by intraperitoneal passage in mice and by antibiotic treatment.
    Hirschberg L; Bölske G; Holme T
    Hybridoma; 1989 Apr; 8(2):249-57. PubMed ID: 2714817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Passage of hybridomas in male BALB/c mice].
    Novikov VV; Trofimova MN; Zhil'tsova MA; Biriukova LZ
    Antibiot Khimioter; 1988 Nov; 33(11):836-8. PubMed ID: 3228324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro stimulation of nonimmunized, naturally infected rat spleen cells for the production of Mycoplasma pulmonis-specific monoclonal antibodies.
    Jarvill KJ; Minion FC
    Hybridoma; 1989 Oct; 8(5):545-50. PubMed ID: 2807312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curing human hybridomas infected with Mycoplasma hyorhinis.
    Borup-Christensen P; Erb K; Jensenius JC
    J Immunol Methods; 1988 Jun; 110(2):237-40. PubMed ID: 3379313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies as probes for antigens of Mycoplasma pulmonis.
    Rose FV; Barile MF; Cebra JJ
    Adv Exp Med Biol; 1983; 162():319-26. PubMed ID: 6191534
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization of T cell hybridomas to establish that a soluble factor derived from Mycoplasma arthritidis is truly a genetically restricted polyclonal T cell activator.
    Yowell RL; Cole BC; Daynes RA
    J Immunol; 1983 Aug; 131(2):543-5. PubMed ID: 6190931
    [No Abstract]   [Full Text] [Related]  

  • 15. Mass production of monoclonal antibody in an ICR mouse using hybridoma cell lines MAC-1 and Aq-12 yields 165 mL ascitic fluid.
    Hasegawa N; Watanabe M; Ohno T
    Hybridoma; 2000 Apr; 19(2):191-2. PubMed ID: 10868801
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies against tumour-associated antigens: mycoplasma as a major technical obstacle and its possible circumvention by azaserine selection medium.
    Karsten U; Rudolph M
    Arch Geschwulstforsch; 1985; 55(5):305-10. PubMed ID: 4062491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to cell surface antigens detected by a rapid spot test using ethidium bromide.
    Cohn ML; Golding H; Rittenberg MB
    J Immunol Methods; 1982; 49(1):75-82. PubMed ID: 6174640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of Mycoplasma contamination from cell lines of different origin by the 5-bromouracil-fluorochrome procedure.
    Calorini L; Ruggieri S
    Cancer Lett; 1989 Jul; 46(2):107-12. PubMed ID: 2473833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against Mycoplasma hyorhinis. A secondary effect of immunization with cultured cells.
    Vennegoor C; Polak-Vogelzang AA; Hekman A
    Exp Cell Res; 1982 Jan; 137(1):89-94. PubMed ID: 7035198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.